Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
Опубликовано в: : | PLoS One 17(2022)10, S. e0274315 |
---|---|
Главные авторы: | Hawchar, Fatime (Автор), Tomescu, Dana (Автор), Henzler, Dietrich (Автор) |
Формат: | Статья |
Язык: | English |
Опубликовано: |
2022
|
Предметы: | |
Online-ссылка: | https://doi.org/10.1371/journal.pone.0274315 |
Связанные документы: | In:
PLoS One |
Схожие документы
-
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
по: Köhler, Thomas, и др.
Опубликовано: (2021) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
по: Köhler, Thomas, и др.
Опубликовано: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
по: Köhler, Thomas, и др.
Опубликовано: (2021) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
по: Schultz, Philipp, и др.
Опубликовано: (2021) -
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry
по: Al-Batran, Salah-Eddin, и др.
Опубликовано: (2021)